Reciprocal modulation of transcriptional activities between HIV-1 Tat and MHC class II transactivator CIITA
- PMID: 11118314
- DOI: 10.1006/bbrc.2000.3972
Reciprocal modulation of transcriptional activities between HIV-1 Tat and MHC class II transactivator CIITA
Abstract
HIV-1 is the etiologic agent of acquired immune deficiency syndrome (AIDS). Functional loss of antigen-presenting cells (APC) in HIV-1 infection is considered to be involved in AIDS pathogenesis. We found that actions of the viral transactivator Tat and the transactivator of MHC class II genes, CIITA, are mutually inhibitory. While Tat inhibited expression of MHC class II genes in APC, overexpression of CIITA inhibited Tat and subsequently HIV-1 replication. This action of Tat appears to be mediated by sequestering the common cofactor, cyclin T1, but not p300 and CBP. These reciprocal actions between Tat and CIITA not only explains the functional impairment of APC in HIV-1 infection but also rationalizes the suppression of HIV-1 virus load by induction of CIITA such as IFN-gamma.
Copyright 2000 Academic Press.
Similar articles
-
The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication.Eur J Immunol. 2002 Oct;32(10):2783-91. doi: 10.1002/1521-4141(2002010)32:10<2783::AID-IMMU2783>3.0.CO;2-E. Eur J Immunol. 2002. PMID: 12355430
-
Inhibition of class II trans-activator function by HIV-1 tat in mouse cells is independent of competition for binding to cyclin T1.Mol Immunol. 2002 Jan;38(7):539-46. doi: 10.1016/s0161-5890(01)00091-8. Mol Immunol. 2002. PMID: 11750655
-
Inhibitory effects of IFN-gamma on HIV-1 replication in latently infected cells.Biochem Biophys Res Commun. 2002 Mar 8;291(4):890-6. doi: 10.1006/bbrc.2002.6532. Biochem Biophys Res Commun. 2002. PMID: 11866448
-
Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.IUBMB Life. 2001 Mar;51(3):175-81. doi: 10.1080/152165401753544241. IUBMB Life. 2001. PMID: 11547919 Review.
-
The HIV-1 Tat transactivator protein: a therapeutic target?IUBMB Life. 2003 Dec;55(12):669-80. doi: 10.1080/15216540310001643440. IUBMB Life. 2003. PMID: 14769003 Review.
Cited by
-
Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.Microbiol Mol Biol Rev. 2018 Jan 10;82(1):e00051-17. doi: 10.1128/MMBR.00051-17. Print 2018 Mar. Microbiol Mol Biol Rev. 2018. PMID: 29321222 Free PMC article.
-
EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes.PLoS Pathog. 2021 Aug 5;17(8):e1009834. doi: 10.1371/journal.ppat.1009834. eCollection 2021 Aug. PLoS Pathog. 2021. PMID: 34352044 Free PMC article.
-
Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.J Virol. 2005 Jul;79(14):9180-91. doi: 10.1128/JVI.79.14.9180-9191.2005. J Virol. 2005. PMID: 15994812 Free PMC article.
-
The Dual Role of the Innate Immune System in the Effectiveness of mRNA Therapeutics.Int J Mol Sci. 2023 Oct 1;24(19):14820. doi: 10.3390/ijms241914820. Int J Mol Sci. 2023. PMID: 37834268 Free PMC article. Review.
-
The class II transactivator requires brahma-related gene 1 to activate transcription of major histocompatibility complex class II genes.Mol Cell Biol. 2002 Jul;22(14):5019-26. doi: 10.1128/MCB.22.14.5019-5026.2002. Mol Cell Biol. 2002. PMID: 12077331 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous